hero section gradient
15 handpicked stocks

U.S.-China Trade Truce | Investment Opportunities

High-level talks between the U.S. and China are underway to prevent the return of tariffs, a critical step for global economic stability. This creates a potential investment opportunity in companies poised to benefit from improved trade relations and the removal of trade barriers.

Author avatar

Han Tan | Market Analyst

Published on September 15

Your Basket's Financial Footprint

Market capitalisation breakdown for a basket focused on U.S.-China trade-related investment opportunities.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer broad-market tracking, suggesting comparatively lower risk.
  • Treat as a potential core holding for diversification rather than a speculative, high-risk growth position.
  • Expect steady, long-term value growth rather than explosive short-term gains; returns are not guaranteed.
Total Market Cap
  • BABA: $397.68B

  • JD: $51.88B

  • BIDU: $40.96B

  • Other

About This Group of Stocks

1

Our Expert Thinking

High-level talks between the U.S. and China are creating a pivotal moment for global markets. We've identified companies that could benefit significantly from improved trade relations and the removal of trade barriers between the world's two largest economies.

2

What You Need to Know

This group focuses on businesses heavily reliant on U.S.-China commerce, particularly in technology, retail, and manufacturing sectors. These companies have significant cross-border supply chains and international sales that make them sensitive to trade policy changes.

3

Why These Stocks

Each company was handpicked by professional analysts based on their exposure to U.S.-China trade dynamics. Their financial performance is closely linked to the outcome of ongoing trade discussions, making this a tactical play on a major geopolitical event.

Why You'll Want to Watch These Stocks

🤝

Historic Trade Talks Underway

High-level officials from the world's two largest economies are meeting in Madrid to prevent a return to trade wars. The outcome could reshape global commerce for years to come.

📈

Supply Chain Relief Ahead

Companies with cross-border operations could see significant cost reductions and renewed market access if negotiations succeed, potentially boosting their valuations.

Geopolitical Opportunity

This curated selection targets businesses whose financial performance is directly tied to U.S.-China relations, making it a tactical play on major global events.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Automotive Semiconductor Gap Explained | Market Shift

Automotive Semiconductor Gap Explained | Market Shift

A major semiconductor supplier's export ban from China is halting vehicle production, creating a potential opening for other chip manufacturers. This theme identifies alternative semiconductor companies poised to fill the critical supply gap for the automotive industry.

Brazil Smart Farming Tech Investment Basket 2025

Brazil Smart Farming Tech Investment Basket 2025

As Brazil solidifies its role as a global agricultural leader, advanced technologies are unlocking new levels of productivity and sustainability for its farms. This basket offers exposure to the US and EU-listed companies providing the essential hardware, software, and data analytics driving this transformation.

Weight-Loss Drug M&A: Valuation Risk Concerns

Weight-Loss Drug M&A: Valuation Risk Concerns

Novo Nordisk's superior bid for Metsera has ignited a bidding war with Pfizer, highlighting the intense M&A activity in the obesity drug market. This theme focuses on other biotech companies with promising weight-loss therapies that could become the next acquisition targets.

Frequently Asked Questions